Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Evaluation of the Cytotoxic Effect of the Brittle Star (Ophiocoma Erinaceus) Dichloromethane Extract and Doxorubicin on EL4 Cell Line.
Afzali M
,
Baharara J
,
Nezhad Shahrokhabadi K
,
Amini E
.
???displayArticle.abstract???
Leukemia is a blood disease that creates from inhibition of differentiation and increased proliferation rate. The nature has been known as a rich source of medically useful substances. High diversity of bioactive molecules, extracted from marine invertebrates, makes them as ideal candidates for cancer research. The study has been done to investigate cytotoxic effects of dichloromethane brittle star extract and doxorubicin on EL4 cancer cells. Blood cancer EL4 cells were cultured and treated at different concentrations of brittle star (
Ophiocoma erinaceus
) dichloromethane extract at 24, 48 and 72 h. Cell toxicity was studied using MTT assay. Cell morphology was examined using an invert microscope. Further, apoptosis was examined using Annexin V-FITC, propodium iodide, DAPI, and Acridine orange/propodium iodide staining. Eventually, the apoptosis pathways were analyzed using measurement of Caspase-3 and -9 activity. The statistical analysis was performed using SPSS, ANOVA software, and Tukey''s test. P<0.05 was considered to be significant. MTT assay and morphological observations showed that dichloromethane extract can inhibit cell growth in a dose dependent. The results considered 32 µg/mL of the extract as IC50. Also, doxorubicin suppressed EL4 proliferation as IC50=32 µg/mL. All experiments related to apoptosis analysis confirmed that dichloromethane brittle star extract and doxorubicin have a cytotoxic effect on EL4 cells inIC50 concentration. The study showed that dichloromethane brittle star extract is as an adjunct to doxorubicin in treatment of leukemia cells.
Figure 1. Morphological effect control groups and groups treated with concentrations of 15, 31, 62, 125, 250 µg/ml brittle star dichloromethane extract O. erinaceus (a) and doxorubicin (b) 24 h after treatment observed by inverted microscope (magnification × 200) A: control, B: 15 µg/ml, C: 31 µg/ml, D: 62 µg/ml, E: 125 µg/ml, F: 250 µg/ml. c) Morphological changes under treatment with co-administration of brittle star dichloromethane extracts and doxorubicin after 24 h treatment. A: control group, B: 7.5 µg/ml DCM and 7.5 µg/ml doxorubicin (IC50) C: 31 µg/ml DCM and 7.5 µg/ml doxorubicin D: 7.5 µg/ml DCM and 31 µg/ml doxorubicin E: 15 µg/ml DCM and 31 µg/ml doxorubicin F: 31 µg/ml DCM and 15 µg/ml doxorubicin. (Magnification × 200).
Figure 4. Apoptosis induced by brittle star dichloromethane fraction on EL4 cells. (A) Control (B) 31 and (C) 62 µg/ml of extract conducted by Annexin V/PI assay
Figure 5. Flow cytometry assessed apoptosis induced by brittle star dichloromethane extract and synergic treatment brittle star dichloromethane extract and Doxorubicin on cells EL4 after staining with PI
Figure 6. a,b.c. The fluorescence images shows AO/PI staining for induction of apoptosis on EL4 cells whit brittle star dichloromethane extract, Doxorubicin and synergic treatment different concentration Doxorubicin and brittle star dichloromethane extract (31, 62 and 7.5 DOX+ 7.5 DCM and 7.5 DOX+31 µg/mL DCM). (A)Control cells and (B) 31 µg/mL DCM (C) 62 µg/mL DCM (D), 31 µg/mL DOX and (E) 62 µg/mL DOX, (F) 7.5 DOX+7.5 DCM , (G) 7.5 DOX+31 DCM µg/mL (Magnification ×200).d) Fluorescence microscopic image of DAPI staining. A (control) B and C (treated EL4 cells with different concentration brittle star dichloromethane extract). (Magnification ×200).
Figure 7. Effect of brittle star dichloromethane extract on Caspase-3 and caspase-9 activities in treated EL4 cells. (A) Histogram represents caspase-3 activity in untreated control and brittle star dichloromethane extract (31, 62 µg/mL). (B) Histogram represents caspase-9 activity in untreated control and brittle star dichloromethane extract (31, 62 µg/mL).
Figure 8. Synergic effect of brittle star dichloromethane extract and Doxorubicin on Caspase-3 and 9 activity in EL4 cells. (A) Histogram represents caspase-3 activity in untreated and synergic treated EL4 cells whit brittle star dichloromethane extract and Doxorubicin (31+7.5 µg/mL) treated EL4 cells. (B) Histogram represents caspase-9 activity in untreated control and brittle star dichloromethane extract (31+7.5 µg/mL).
Althunibat,
Antioxidant and cytotoxic properties of two sea cucumbers, Holothuria edulis lesson and Stichopus horrens Selenka.
2013, Pubmed,
Echinobase
Althunibat,
Antioxidant and cytotoxic properties of two sea cucumbers, Holothuria edulis lesson and Stichopus horrens Selenka.
2013,
Pubmed
,
Echinobase
De Zoysa,
Medicinal benefits of marine invertebrates: sources for discovering natural drug candidates.
2012,
Pubmed
Demain,
Natural products for cancer chemotherapy.
2011,
Pubmed
Ebrahimi,
Effects of Dietary Honey andArdehCombination on Chemotherapy- Induced Gastrointestinal and Infectious Complications in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Clinical Trial.
2016,
Pubmed
Edwards,
Marine compounds selectively induce apoptosis in female reproductive cancer cells but not in primary-derived human reproductive granulosa cells.
2012,
Pubmed
Gocek,
Differentiation therapy of acute myeloid leukemia.
2011,
Pubmed
Jo,
Methanolic Extract of Asterina pectinifera inhibits LPS-Induced Inflammatory Mediators in Murine Macrophage.
2010,
Pubmed
,
Echinobase
Kakanj,
Cytotoxic Effect of Iranian Vipera lebetina Snake Venom on HUVEC Cells.
2015,
Pubmed
Kovar,
Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells.
2010,
Pubmed
Levina,
[Steroidal compounds from the Pacific starfish Mithrodia clavigera and their toxic properties against human melanoma cells].
2012,
Pubmed
,
Echinobase
Malyarenko,
Asterosaponins from the Far Eastern starfish Leptasterias ochotensis and their anticancer activity.
2014,
Pubmed
,
Echinobase
Mutee,
Evaluation of anti-cancer activity of Acanthester planci extracts obtained by different methods of extraction.
2012,
Pubmed
,
Echinobase
Octavia,
Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
2012,
Pubmed
Sankari,
Apoptosis in cancer--an update.
2012,
Pubmed
Sawadogo,
A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.
2013,
Pubmed
Smith,
Echinoderm immunity.
2010,
Pubmed
,
Echinobase
Suarez-Jimenez,
Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.
2012,
Pubmed